author-photo

Louis M. Aledort

Icahn School of Medicine at Mount Sinai
Mount Sinai Hospital

283

Papers

9490

Citations

Citation Trend

Filter By

Papers (204) Sort By

Journal Conference Others

Convalescent plasma for administration of passive antibodies against viral agents.

2020 Haematologica
Show All
- Source
- Cite
- Save
Citations (0)
Subtleties in the administration of obtained hemophilia an out of an old patient with huge granular lymphocytic leukemia

2020
- Louis M. Aledort
Show All
- Source
- Cite
- Save
Citations (0)
Emicizumab in Hemophilia A. Reply.

2020 The New England Journal of Medicine
- Louis M. Aledort
Show All
- Source
- Cite
- Save
Citations (0)
Why plasma-derived factor VIII?

2019 Haemophilia
Show All
- Source
- Cite
- Save
Citations (1)
Factor VIII replacement is still the standard of care in haemophilia A.

2019 Blood Transfusion
Show All
- Source
- Cite
- Save
Citations (19)
The ongoing imperative for immune tolerance induction in inhibitor management

2019 Haemophilia
- Louis M. Aledort
Show All
- Source
- Cite
- Save
Citations (3)
Deaths Associated with Emicizumab in Patients with Hemophilia A

2019 The New England Journal of Medicine
- Louis M. Aledort
Show All
- Source
- Cite
- Save
Citations (11)
Prophylaxis re‐visited: The potential impact of novel factor and non‐factor therapies on prophylaxis

2018 Haemophilia
Show All
- Source
- Cite
- Save
Citations (4)
Evaluating the safety of emicizumab in patients with hemophilia A

2018 Expert Opinion on Drug Safety
Show All
- Source
- Cite
- Save
Citations (12)
Fifth Åland Island conference on von Willebrand disease

2018 Haemophilia
Show All
- Source
- Cite
- Save
Citations (9)